Acetimidamide Antimicrobial Synthesis via One-Pot Reaction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a growing need for new antimicrobial agents effective against drug-resistant microorganisms, and existing methods face challenges in synthesizing compounds with high yields, efficient reaction times, and solvent-free processes using recyclable catalysts.

Innovation Solution

A 2-(benzo[d]oxazol-2-yl)-N′-(4-(dimethylamino)benzoyloxy)acetimidamide compound is synthesized via a one-pot three-component reaction using (1,3-benzoxazol-2-yl)acetonitrile, 4-(dimethylamino)benzoic acid, and carbonyldiimidazole in acetonitrile, demonstrating excellent antimicrobial activity against various microbes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional antibiotic synthesis methods are used, then antimicrobial agents can be produced, but the microorganisms develop resistance reducing effectiveness

Engineering Contradiction:
Improveantimicrobial effectivenessVSAvoidmicrobial resistance
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the molecular structure by incorporating a 1,3-benzoxazole nucleus with specific substituents (amidine group, hydroxyl group) to create novel compounds with altered pharmacological properties that overcome existing microbial resistance mechanisms

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The compound combines multiple functional groups (benzoxazole core, amidine group, hydroxyl group) into a single molecule, creating a composite structure that exhibits enhanced and multifaceted antimicrobial activity against resistant strains

Inventive Principle:
Principle #40Composite materials

2Ease of manufacture

If traditional synthesis methods are used for new antimicrobial compounds, then compounds can be produced, but the synthesis is difficult with low yield and long reaction times

Engineering Contradiction:
Improvesynthesis difficultyVSAvoidsynthesis efficiency
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent employs a one-pot three-component reaction that combines (1,3-benzoxazol-2-yl)acetonitrile, 4-(dimethylamino)benzoic acid, and carbonyldiimidazole in a single reaction vessel to directly produce the target compound, eliminating multiple isolation and purification steps

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

Carbonyldiimidazole serves as a coupling agent that facilitates the reaction between the carboxylic acid and nitrile components, enabling efficient formation of the imidamide bond under mild conditions with high yield

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If conventional synthesis procedures are used, then compounds can be synthesized, but solvents are required which complicates the process and reduces efficiency

Engineering Contradiction:
Improvereaction efficiencyVSAvoidsolvent usage
Core Design Contradiction:
ProductivityVSLoss of substance

Solution Approach 1:

The patent eliminates the need for additional solvents by utilizing acetonitrile both as a reactant component and as the reaction medium, thereby removing the separate solvent step and associated purification requirements

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compound achieves satisfactory yields and exhibits strong antibacterial and antifungal activities against gram-positive and gram-negative bacteria, as well as fungi, providing a promising therapeutic option for microbial infections.

Implementation Method 1

using carbonyldiimidazole (CDI) as a catalyst in acetonitrile

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS11905259B12-(benzo[d]oxazol-2-yl)-N′-(4-(dimethylamino)benzoyloxy)acetimidamide as an antimicrobial compound
Publication Date: 2024.02.20 KING FAISAL UNIV
  • US11905259B1 patent drawing
  • US11905259B1 patent drawing
  • US11905259B1 patent drawing

AI summary

A 2-(benzo[d]oxazol-2-yl)-N′-(4-(dimethylamino)benzoyloxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.